Transduction of Bone-Marrow-Derived Mesenchymal Stem Cells by Using Lentivirus Vectors Pseudotyped with Modified RD114 Envelope Glycoproteins

Journal of Virology - Tập 78 Số 3 - Trang 1219-1229 - 2004
Xian-Yang Zhang1, Vincent F. La Russa2, Jakob Reiser1
1Gene Therapy Program, Department of Medicine, and Department of Microbiology, Immunology and Parasitology, LSU Health Sciences Center
2Bone Marrow Transplantation Laboratory, Tulane Cancer Center, New Orleans, Louisiana 70112

Tóm tắt

ABSTRACT Bone-marrow-derived mesenchymal stem cells (MSCs) have attracted considerable attention as tools for the systemic delivery of therapeutic proteins in vivo, and the ability to efficiently transfer genes of interest into such cells would create a number of therapeutic opportunities. We have designed and tested a series of human immunodeficiency virus type 1 (HIV-1)-based vectors and vectors based on the oncogenic murine stem cell virus to deliver and express transgenes in human MSCs. These vectors were pseudotyped with either the vesicular stomatitis virus G (VSV-G) glycoprotein (GP) or the feline endogenous virus RD114 envelope GP. Transduction efficiencies and transgene expression levels in MSCs were analyzed by quantitative flow cytometry and quantitative real-time PCR. While transduction efficiencies with virus particles pseudotyped with the VSV-G GP were found to be high, RD114 pseudotypes revealed transduction efficiencies that were 1 to 2 orders of magnitude below those observed with VSV-G pseudotypes. However, chimeric RD114 GPs, with the transmembrane and extracellular domains fused to the cytoplasmic domain derived from the amphotropic Moloney murine leukemia virus 4070A GP, revealed about 15-fold higher titers relative to the unmodified RD114 GP. The transduction efficiencies in human MSCs of HIV-1-based vectors pseudotyped with the chimeric RD114 GP were similar to those obtained with HIV-1 vectors pseudotyped with the VSV-G GP. Our results also indicate that RD114 pseudotypes were less toxic than VSV-G pseudotypes in human MSC progenitor assays. Taken together, these results suggest that lentivirus pseudotypes bearing alternative Env GPs provide efficient tools for ex vivo modification of human MSCs.

Từ khóa


Tài liệu tham khảo

10.1128/jvi.59.2.284-291.1986

10.1089/hum.1997.8.12-1417

10.1089/10430340152480258

10.1182/blood.V99.5.1857

10.1128/JVI.76.3.1488-1495.2002

10.1634/stemcells.19-3-180

10.1182/blood.V88.5.1887.1887

10.1016/S0092-8674(85)80025-8

10.1182/blood.V56.2.289.289

10.1128/jvi.74.10.4933-4937.2000

10.1038/sj.gt.3300507

10.1089/hum.1998.9.10-1397

10.1089/10430349950019192

10.1634/stemcells.19-3-236

10.1128/JVI.75.9.4129-4138.2001

10.1089/hum.1998.9.3-353

10.1089/10430340050015626

10.1016/S0301-472X(00)00134-X

10.1128/jvi.69.12.7430-7436.1995

10.1016/S0301-472X(00)00482-3

10.1038/sj.gt.3300973

10.1128/mcb.7.1.379-387.1987

10.1128/MCB.16.6.2958

Friedenstein, A. J., J. F. Gorskaja, and N. N. Kulagina. 1976. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp. Hematol.4:267-274.

10.1089/152581600419260

10.1634/stemcells.19-3-247

10.1038/6470

10.1089/hum.1997.8.11-1385

10.1038/sj.gt.3301772

10.1006/mthe.2002.0549

Hawley, R. G., F. H. Lieu, A. Z. Fong, and T. S. Hawley. 1994. Versatile retroviral vectors for potential use in gene therapy. Gene Ther.1:136-138.

10.1089/hum.1997.8.2-137

10.1038/nbt815

10.1089/10430340050129468

10.1128/JVI.75.14.6537-6546.2001

10.1038/85664

10.1006/mthe.2002.0603

10.1002/jgm.292

10.1089/10430340360464723

10.1128/jvi.66.8.5110-5113.1992

10.1128/jvi.65.1.162-169.1991

10.1006/mthe.2001.0327

10.1128/JVI.75.19.9339-9344.2001

Marino M. P. M. J. Luce and J. Reiser. 2003. Small-to high-scale production of lentivirus vectors. Methods Mol. Biol. 229:43-55.

10.1023/A:1020256924099

10.1089/10430349950018157

10.1038/sj.gt.3301232

10.1089/104303401750214258

10.1016/S0145-2126(01)00134-5

10.1177/153537020122600603

10.1128/JVI.72.11.8873-8883.1998

10.1126/science.272.5259.263

10.1016/0378-1119(91)90434-D

10.1182/blood.V83.10.3041.3041

10.1016/0378-1119(95)00731-8

10.1073/pnas.92.11.4857

10.1126/science.284.5411.143

10.1089/hum.1996.7.8-913

10.1038/sj.gt.3301188

10.1073/pnas.93.26.15266

10.1128/JVI.74.22.10589-10599.2000

10.1006/exnr.2000.7389

10.1182/blood-2001-11-0042

10.1089/10430349950016870

10.1038/sj.gt.3301517

10.1093/nar/23.4.628

10.1038/345640a0

10.1006/viro.2000.0394

10.1128/jvi.70.10.7322-7326.1996

10.1038/nbt0597-458

10.1128/jvi.68.12.8001-8007.1994

10.1016/S1525-0016(02)00062-X

10.1006/mthe.2002.0585

Zhang X. Y. V. F. La Russa and J. Reiser. 2003. Mesenchymal stem cells. Methods Mol. Biol. 229:131-140.